JP2010517990A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010517990A5 JP2010517990A5 JP2009547778A JP2009547778A JP2010517990A5 JP 2010517990 A5 JP2010517990 A5 JP 2010517990A5 JP 2009547778 A JP2009547778 A JP 2009547778A JP 2009547778 A JP2009547778 A JP 2009547778A JP 2010517990 A5 JP2010517990 A5 JP 2010517990A5
- Authority
- JP
- Japan
- Prior art keywords
- condition
- composition
- compound
- composition according
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 3
- 208000024827 Alzheimer disease Diseases 0.000 claims 2
- 201000004624 Dermatitis Diseases 0.000 claims 2
- 102000003676 Glucocorticoid Receptors Human genes 0.000 claims 2
- 108090000079 Glucocorticoid Receptors Proteins 0.000 claims 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 2
- 208000006673 asthma Diseases 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 208000028017 Psychotic disease Diseases 0.000 claims 1
- 206010052779 Transplant rejections Diseases 0.000 claims 1
- 206010046851 Uveitis Diseases 0.000 claims 1
- 159000000007 calcium salts Chemical class 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 208000024714 major depressive disease Diseases 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 201000001119 neuropathy Diseases 0.000 claims 1
- 230000007823 neuropathy Effects 0.000 claims 1
- 208000033808 peripheral neuropathy Diseases 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 159000000000 sodium salts Chemical class 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88798107P | 2007-02-02 | 2007-02-02 | |
| PCT/IB2008/000229 WO2008093227A1 (en) | 2007-02-02 | 2008-01-25 | Tricyclic compounds and their use as glucocorticoid receptor modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010517990A JP2010517990A (ja) | 2010-05-27 |
| JP2010517990A5 true JP2010517990A5 (enExample) | 2010-08-12 |
| JP4599462B2 JP4599462B2 (ja) | 2010-12-15 |
Family
ID=39315208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009547778A Expired - Fee Related JP4599462B2 (ja) | 2007-02-02 | 2008-01-25 | 三環式化合物およびそれらのグルココルチコイド受容体調節剤としての使用 |
Country Status (42)
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6001876A (en) | 1996-07-24 | 1999-12-14 | Warner-Lambert Company | Isobutylgaba and its derivatives for the treatment of pain |
| WO2008093227A1 (en) * | 2007-02-02 | 2008-08-07 | Pfizer Products Inc. | Tricyclic compounds and their use as glucocorticoid receptor modulators |
| ES2527137T3 (es) * | 2008-07-28 | 2015-01-21 | Pfizer Inc. | Compuestos de fenantrenona, composiciones y procedimientos |
| US8765787B2 (en) * | 2008-11-21 | 2014-07-01 | Bridge Pharma, Inc. | Methods of treatment of xerophthalmia with self-preserving ocular formulations of norketotifen |
| US20100137844A1 (en) * | 2008-12-02 | 2010-06-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Delivery devices for modulating inflammation |
| US20100136097A1 (en) * | 2008-12-02 | 2010-06-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Systems for modulating inflammation |
| US20100136096A1 (en) * | 2008-12-02 | 2010-06-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Systems for modulating inflammation |
| US20100136095A1 (en) * | 2008-12-02 | 2010-06-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Systems for modulating inflammation |
| US20100136094A1 (en) * | 2008-12-02 | 2010-06-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Systems for modulating inflammation |
| US20100137246A1 (en) * | 2008-12-02 | 2010-06-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Anti-inflammatory compositions and methods |
| US20100135983A1 (en) * | 2008-12-02 | 2010-06-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Anti-inflammatory compositions and methods |
| EP2569307A2 (en) | 2010-05-10 | 2013-03-20 | Radikal Therapeutics Inc. | Lipoic acid and nitroxide derivatives and uses thereof |
| MX2013002186A (es) * | 2010-08-27 | 2013-06-28 | Corcept Therapeutics Inc | Moduladores de azadecalina de piridil-amina fusionada. |
| WO2012125797A1 (en) * | 2011-03-15 | 2012-09-20 | Abbott Laboratories | Nuclear hormone receptor modulators |
| US8545904B1 (en) | 2012-06-05 | 2013-10-01 | Liquid Innovators, LLC | Topical composition containing Carapa (andiroba) oil for psoriasis and other related dermatological disorders |
| US9227901B2 (en) * | 2012-07-05 | 2016-01-05 | Abbvie Inc. | Process for preparing bicyclic amine derivatives |
| TW201422590A (zh) | 2012-09-07 | 2014-06-16 | Abbvie Inc | 雜環核激素受體調節劑 |
| EP2935284A4 (en) | 2012-12-21 | 2016-04-27 | Abbvie Inc | HETEROCYCLIC MODULATORS OF HORMONE NUCLEAR RECEPTORS |
| AU2015258904A1 (en) | 2014-05-16 | 2016-11-17 | Liqwd, Inc. | Keratin treatment formulations and methods |
| EP3848028B9 (en) | 2014-10-20 | 2024-10-16 | Oyster Point Pharma, Inc. | Methods of treating ocular conditions |
| CN104591988A (zh) * | 2014-12-29 | 2015-05-06 | 甘肃省化工研究院 | 6-溴-2-萘满酮的合成方法 |
| US10722513B2 (en) * | 2015-03-23 | 2020-07-28 | The University Of Melbourne | Treatment of respiratory diseases |
| DK3439661T3 (da) | 2016-04-07 | 2021-10-18 | Oyster Point Pharma Inc | Fremgangsmåder til behandling af øjenlidelser |
| EP3877382B1 (en) | 2018-11-07 | 2026-03-18 | Tianli Biotech Pty Ltd | Novel compounds for the treatment of respiratory diseases |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2576025B1 (fr) | 1985-01-14 | 1987-01-23 | Roussel Uclaf | Nouveaux steroides substitues en position 10, leur procede et les intermediaires de preparation, leur application comme medicaments, les compositions pharmaceutiques les contenant |
| FR2600450B1 (fr) * | 1986-06-19 | 1988-08-26 | Pechiney Aluminium | Procede de marquage individuel des anodes precuites pour la production electrolytique d'aluminium |
| GB9518953D0 (en) * | 1995-09-15 | 1995-11-15 | Pfizer Ltd | Pharmaceutical formulations |
| IL122740A (en) | 1997-01-15 | 2003-09-17 | Akzo Nobel Nv | 16-hydroxy-11-(substituted phenyl)-estra-9,4-diene derivatives, their preparation and pharmaceutical compositions containing them |
| HK1042889B (zh) | 1999-04-30 | 2006-12-29 | 辉瑞产品公司 | 糖皮质激素受体调制剂 |
| US6544781B1 (en) | 1999-07-15 | 2003-04-08 | The General Hospital Corporation | Non-defective Epstein-Barr viral vector |
| IL180679A0 (en) * | 2000-10-27 | 2009-02-11 | Pfizer Prod Inc | Process for the preparation of non-steroidal glucocorticoid receptor modulators |
| JP2002193911A (ja) * | 2000-10-28 | 2002-07-10 | Pfizer Prod Inc | グルココルチコイドレセプターモジュレーター |
| ES2246292T3 (es) | 2000-10-30 | 2006-02-16 | Pfizer Products Inc. | Moduladores de receptor glucocorticoide. |
| GB2387468B (en) * | 2000-11-20 | 2005-01-19 | Seagate Technology Llc | RF ID Tag attachment to a disc drive |
| MXPA03011935A (es) | 2001-06-22 | 2004-03-26 | Pfizer Prod Inc | Composiciones farmaceuticas que contienen conjuntos de polimero y farmaco. |
| CN1556708A (zh) | 2001-08-31 | 2004-12-22 | �Ƹ��� | 抑制成年唐氏综合症患者认知退化的方法 |
| EP1432684B1 (en) | 2001-09-27 | 2009-03-25 | Université de Liège | Pyridinic sulfonamide derivatives, method of production and use thereof |
| DE10164366C1 (de) * | 2001-12-28 | 2003-06-05 | Rehau Ag & Co | Permanentkathode |
| WO2003063833A1 (en) | 2002-02-01 | 2003-08-07 | Pfizer Products Inc. | Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials |
| JP2005535664A (ja) | 2002-07-02 | 2005-11-24 | コーセプト セラピューティクス， インコーポレイテッド | インターフェロン−α治療に関連した精神病を処置するための方法 |
| ES2518940T3 (es) * | 2002-07-08 | 2014-11-06 | Pfizer Products Inc. | Moduladores del receptor de glucocorticoides |
| EP1581234A4 (en) | 2002-11-05 | 2007-09-12 | Corcept Therapeutics Inc | METHODS FOR TREATING MIGRAINE |
| US20040229855A1 (en) | 2003-02-04 | 2004-11-18 | Corcept Therapeutics, Inc. | Antiglucocorticoids for the treatment of postpartum psychosis |
| US20050080061A1 (en) | 2003-07-23 | 2005-04-14 | Corcept Therapeutics, Inc. | Antiglucocorticoid therapy for the prevention of neurological damage in premature infants |
| US8097606B2 (en) | 2003-07-23 | 2012-01-17 | Corcept Therapeutics, Inc. | Antiglucocorticoids for the treatment of catatonia |
| TW200512181A (en) | 2003-09-26 | 2005-04-01 | Tanabe Seiyaku Co | Amide-type carboxamide derivatives |
| US7592177B2 (en) * | 2003-11-10 | 2009-09-22 | The Scripps Research Institute | Compositions and methods for inducing cell dedifferentiation |
| AU2004289532A1 (en) * | 2003-11-13 | 2005-05-26 | Pfizer Products Inc. | Octahydrophenanthrene hydrazinde derivatives useful as glucocorticoid receptor modulators |
| TWI370129B (en) | 2005-02-14 | 2012-08-11 | Msd Oss Bv | Non steroidal glucocorticoid receptor modulators |
| AU2007248059A1 (en) | 2006-05-02 | 2007-11-15 | Corcept Therapeutics, Inc. | The use of a glucocorticoid receptor ii antagonist to treat depression in patients taking il-2 |
| WO2008093227A1 (en) * | 2007-02-02 | 2008-08-07 | Pfizer Products Inc. | Tricyclic compounds and their use as glucocorticoid receptor modulators |
| AU2008211622B2 (en) * | 2007-02-02 | 2012-04-19 | Pfizer Products Inc. | Tricyclic compounds and their use as glucocorticoid receptor modulators |
-
2008
- 2008-01-25 WO PCT/IB2008/000229 patent/WO2008093227A1/en not_active Ceased
- 2008-01-25 ES ES08702351T patent/ES2368286T3/es active Active
- 2008-01-25 JP JP2009547778A patent/JP4599462B2/ja not_active Expired - Fee Related
- 2008-01-25 PT PT08702351T patent/PT2114970E/pt unknown
- 2008-01-25 DK DK08702351.1T patent/DK2114970T3/da active
- 2008-01-25 MY MYPI20093089A patent/MY146087A/en unknown
- 2008-01-25 GE GEAP200811399A patent/GEP20125404B/en unknown
- 2008-01-25 MY MYPI20123293 patent/MY153057A/en unknown
- 2008-01-25 AU AU2008211613A patent/AU2008211613B2/en not_active Ceased
- 2008-01-25 CA CA2676670A patent/CA2676670C/en not_active Expired - Fee Related
- 2008-01-25 BR BRPI0808634-6A patent/BRPI0808634A2/pt not_active IP Right Cessation
- 2008-01-25 AT AT08702351T patent/ATE518872T1/de active
- 2008-01-25 MX MX2009008284A patent/MX2009008284A/es active IP Right Grant
- 2008-01-25 KR KR1020097018289A patent/KR101107949B1/ko not_active Expired - Fee Related
- 2008-01-25 EP EP08702351A patent/EP2114970B1/en active Active
- 2008-01-25 UA UAA200907728A patent/UA94639C2/ru unknown
- 2008-01-25 NZ NZ578638A patent/NZ578638A/en not_active IP Right Cessation
- 2008-01-25 CN CN2008800052954A patent/CN101616925B/zh not_active Expired - Fee Related
- 2008-01-25 PL PL08702351T patent/PL2114970T3/pl unknown
- 2008-01-25 HR HR20110702T patent/HRP20110702T1/hr unknown
- 2008-01-25 EA EA200970666A patent/EA016494B1/ru not_active IP Right Cessation
- 2008-01-25 RS RS20110429A patent/RS51970B/sr unknown
- 2008-01-25 AP AP2009004942A patent/AP2455A/xx active
- 2008-01-25 SI SI200830393T patent/SI2114970T1/sl unknown
- 2008-01-28 CN CN2008800056527A patent/CN101616896B/zh not_active Expired - Fee Related
- 2008-01-28 RS RS20110008A patent/RS51646B/sr unknown
- 2008-01-28 PT PT08702358T patent/PT2114888E/pt unknown
- 2008-01-28 MY MYPI20093135A patent/MY148780A/en unknown
- 2008-01-28 ES ES08702358T patent/ES2353822T3/es active Active
- 2008-01-28 GE GEAP200811398A patent/GEP20125426B/en unknown
- 2008-01-28 UA UAA200907730A patent/UA95332C2/uk unknown
- 2008-01-28 KR KR1020097018294A patent/KR101114682B1/ko not_active Expired - Fee Related
- 2008-01-31 US US12/023,362 patent/US7598231B2/en not_active Expired - Fee Related
- 2008-01-31 PE PE2008000231A patent/PE20081736A1/es not_active Application Discontinuation
- 2008-01-31 US US12/023,323 patent/US7547714B2/en not_active Expired - Fee Related
- 2008-02-01 HN HN2008000178A patent/HN2008000178A/es unknown
- 2008-02-01 PE PE2008000234A patent/PE20090113A1/es not_active Application Discontinuation
- 2008-02-01 CL CL200800330A patent/CL2008000330A1/es unknown
- 2008-02-01 TW TW097104074A patent/TWI373466B/zh not_active IP Right Cessation
- 2008-02-01 AR ARP080100424A patent/AR065134A1/es active IP Right Grant
- 2008-02-01 HN HN2008000179A patent/HN2008000179A/es unknown
- 2008-02-01 TW TW097104089A patent/TWI347842B/zh active
- 2008-02-01 CL CL200800329A patent/CL2008000329A1/es unknown
- 2008-02-01 AR ARP080100425A patent/AR065135A1/es active IP Right Grant
-
2009
- 2009-05-08 US US12/437,704 patent/US8158660B2/en not_active Expired - Fee Related
- 2009-07-20 IL IL199972A patent/IL199972A/en active IP Right Grant
- 2009-07-21 US US12/506,825 patent/US7786097B2/en not_active Expired - Fee Related
- 2009-07-23 CR CR10949A patent/CR10949A/es not_active IP Right Cessation
- 2009-07-23 CR CR10948A patent/CR10948A/es not_active IP Right Cessation
- 2009-07-24 CU CU2009000132A patent/CU23848B1/es active IP Right Grant
- 2009-07-24 CU CU20090133A patent/CU20090133A7/es active IP Right Grant
- 2009-07-29 DO DO2009000190A patent/DOP2009000190A/es unknown
- 2009-07-29 NI NI200900148A patent/NI200900148A/es unknown
- 2009-07-29 NI NI200900149A patent/NI200900149A/es unknown
- 2009-07-30 GT GT200900209A patent/GT200900209A/es unknown
- 2009-07-30 GT GT200900210A patent/GT200900210A/es unknown
- 2009-07-30 SV SV2009003346A patent/SV2009003346A/es not_active Application Discontinuation
- 2009-07-31 CO CO09079789A patent/CO6220937A2/es active IP Right Grant
- 2009-07-31 SV SV2009003349A patent/SV2009003349A/es active IP Right Grant
- 2009-07-31 TN TNP2009000324A patent/TN2009000324A1/fr unknown
- 2009-07-31 EC EC2009009553A patent/ECSP099553A/es unknown
- 2009-07-31 MA MA32127A patent/MA31117B1/fr unknown
- 2009-07-31 EC EC2009009552A patent/ECSP099552A/es unknown
- 2009-07-31 CO CO09079796A patent/CO6190603A2/es active IP Right Grant
- 2009-07-31 MA MA32128A patent/MA31158B1/fr unknown
- 2009-09-01 ZA ZA200906064A patent/ZA200906064B/xx unknown
- 2009-09-01 ZA ZA200906060A patent/ZA200906060B/xx unknown
-
2010
- 2010-12-02 CY CY20101101109T patent/CY1110962T1/el unknown
-
2011
- 2011-08-17 CY CY20111100784T patent/CY1111758T1/el unknown
- 2011-12-21 US US13/333,104 patent/US8445520B2/en not_active Expired - Fee Related
-
2013
- 2013-04-16 US US13/863,534 patent/US20140142316A1/en not_active Abandoned
-
2014
- 2014-07-01 US US14/320,674 patent/US8901310B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010533203A5 (enExample) | ||
| CA2676670A1 (en) | Tricyclic compounds, compositions, and methods | |
| JP2010536766A5 (enExample) | ||
| JP2010517991A5 (enExample) | ||
| JP2011518833A5 (enExample) | ||
| JP2007535611A5 (enExample) | ||
| JP2014029971A5 (ja) | 有機化合物 | |
| JP2011513196A5 (enExample) | ||
| JP2010534247A5 (enExample) | ||
| JP2011105732A5 (enExample) | ||
| JP2010501534A5 (enExample) | ||
| JP2010141309A5 (ja) | 発光素子 | |
| JP2009149903A5 (enExample) | ||
| JP2011500769A5 (enExample) | ||
| JP2014514960A5 (enExample) | ||
| JP2010530897A5 (enExample) | ||
| JP2013010749A5 (ja) | カルバゾール化合物 | |
| JP2010530373A5 (enExample) | ||
| JP2013010730A5 (ja) | フルオレン化合物および有機化合物 | |
| JP2010516852A5 (enExample) | ||
| CA2676907A1 (en) | Tricyclic compounds and their use as glucocorticoid receptor modulators | |
| JP2012502876A5 (enExample) | ||
| JP2014097964A5 (enExample) | ||
| JP2014028784A5 (ja) | 複素環化合物および有機化合物 | |
| JP2011519825A5 (enExample) |